Welcome to the MD Analytics Panel!
You have joined an exclusive group of Canadian healthcare professionals, who wish to participate in market research.
This is what you can expect as a member of our panel:
- You will receive invitations by email to participate in market research studies that are relevant to your profession. (Please add firstname.lastname@example.org to your safe sender list.)
- The survey invitation will always clearly communicate to you the format of the study you are being invited to participate in, estimated length of the study, and the incentive amount.
- As our studies often fill quickly, we urge you to participate as soon as you can.
We do our very best to ensure that the studies we send your way are pertinent to your practice. Keeping your profile up to date will help us better identify studies that are most relevant to you.
All studies that we conduct contain a set of screening questions at the beginning of the study. To learn more about why these are necessary, please read our post on the importance of screeners.
At any time, should you have questions or require support with a study, please contact us and one of our team members will help you.
We look forward to your participation.
Latest Survey Data
We are sometimes reminded with stories, movies and books that companies have an origin too. It must have started somehow. Someone must have had a vision or an idea and then worked hard to get it going.
MD Analytics is no different in this way and its story follows its own certain path with many team members supporting the company’s growth and quality deliverables throughout the years. At the forefront is the CEO, Tyler Hassman, a fourth generation Canadian, born in Saskatchewan who migrated to British Columbia in the late 90’s; where he held several sales positions during the “dot com” days and met other ambitious soon-to-be entrepreneurs along the way. Working long hours tirelessly and then meeting with friends after work to talk about business was the way he spent most of his days. Day after day, year after year working and evolving along with the business.
Since its initial onset, COVID-19 has had a significant impact on how physicians interact with pharmaceutical companies. Government restrictions forced companies to quickly adapt and move to more remote forms of interactions. While in-person interactions are once again a viable option for communication, will they return to pre-pandemic levels? MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 50 Canadian GPs and 90 Canadian specialists in our latest survey on the topic.
With COVID-19 about to enter its 3rd year, it continues to significantly impact the lives of Canadians and the practices of HCPs in the country. Even though it has not been easy, physicians have continuously adapted how they manage their patients and how they interact with key healthcare stakeholders during the pandemic. MD Analytics has been monitoring these trends over the past few years and we have recently interviewed 140 physicians in our latest survey on the topic.